Posted 18 September, 2023

RayzeBio, Inc. IPO completed

IPO completed detected for ticker Nasdaq:RYZB in a 424B4 filed on 18 September, 2023.

  This is the initial public offering of RayzeBio, Inc.  

Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of RayzeBio, Inc.
Health Care/Life Sciences • Pharmaceuticals
RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.
Market Cap
View Company Details